Canaan XI L.P.

Director at AEVA; Director at TYRA; 10% owner at DAWN

Sold, on record
$11.4M
Dollars the filings state
Form 4 sales
1
Latest Sep 21, 2022
Form 144 notices
3
Proposed sales
Companies
3
Filed as an executive or holder

Companies

  • AEVAAeva Technologies, Inc.Director
  • TYRATyra Biosciences, Inc.Director
  • DAWNDay One Biopharmaceuticals, Inc.10% owner

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale DAWNPlan not stated
    Sep 21, 2022 2022

    Sold 613,603 shares at $18.55 ($11.4M)

    Canaan XI L.P., 10% owner

    Sold 6.8% of holdings ($168M position)8.5M shares leftFirst sale on recordFiling

  2. 2 Form 144 notice TYRANotice
    Oct 30, 2024 +770 days

    Filed to sell 234,000 shares ($3.7M)

    Canaan XI L.P., Director

    No 10b5-1 planFirst sale on recordFiling

  3. 3 Form 144 notice TYRANotice
    Feb 5, 2025 +98 days

    Filed to sell 120,000 shares ($1.6M)

    Canaan XI L.P., Director

    No 10b5-1 planFirst sale on recordFiling

  4. 4 Form 144 notice AEVANotice
    Jun 16, 2025 +131 days

    Filed to sell 100,000 shares ($2.5M)

    Canaan XI L.P., Director

    No 10b5-1 planFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Canaan XI L.P.
Source
Jun 16, 2025Jun 16, 2025AEVADirectorForm 144 notice100,000$2.5MNoticeSEC
Feb 5, 2025Feb 5, 2025TYRADirectorForm 144 notice120,000$1.6MNoticeSEC
Oct 30, 2024Oct 30, 2024TYRADirectorForm 144 notice234,000$3.7MNoticeSEC
Sep 21, 2022Sep 22, 2022DAWN10% ownerForm 4 sale613,603$11.4M6.8%Plan not statedSEC